Enabling Stabilization, Purification, and Handling of Highly Reactive Catechol Metabolites of MDMA: Synthesis of 3,4-Dihydroxyamphetamine (HHA) and 3,4-Dihydroxymethamphetamine (HHMA) as Certified Reference Standards Addressing a Fifty-Year Gap in Methodological Documentation - Draft

Read full text Summarise with VIRAT
Authors: David Vonlanthen
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

3,4-Dihydroxyamphetamine (HHA) and 3,4-dihydroxymethamphetamine (HHMA) are the principal catecholic metabolites of MDMA ("ecstasy") and are required as certified reference standards (CRMs) for GMP-grade bioanalytical methods in clinical pharmacology and forensic toxicology. Their structural combination of an ortho-catechol moiety with a proximal unhindered aliphatic amine drives an irreversible oxidative cascade — autoxidation, intramolecular aza-Michael cyclisation, and aromatisation to melanin-type polymers — that renders both compounds acutely unstable under ambient conditions. This note describes the synthetic strategy (dibenzyl ether protection / catalytic hydrogenolysis under inert atmosphere), the purification approach (RP-8 MPLC with 1% aqueous HCl / isopropanol), and the critical handling conditions (pH ≤1, inert atmosphere, −20°C) required to obtain and maintain these metabolites in analytically useful form. A mechanistic rationale for each precaution is provided. The relevance to ongoing GMP clinical investigations of MDMA-assisted therapy and to ICH M10-compliant bioanalytical method validation is discussed.

Fields of Study & Subjects

Forensic Toxicology and Drug Analysis Analytical Methods in Pharmaceuticals Psychedelics and Drug Studies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 March 2026
Language
EN
Document type
Preprint